Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range

被引:762
作者
Hirsh, J [1 ]
Dalen, JE [1 ]
Anderson, DR [1 ]
Poller, L [1 ]
Bussey, H [1 ]
Ansell, J [1 ]
Deykin, D [1 ]
机构
[1] Hamilton Civ Hosp Res Ctr, Hamilton, ON L8V 1C3, Canada
关键词
D O I
10.1378/chest.119.1_suppl.8S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:8S / 21S
页数:14
相关论文
共 163 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]   STROKE PREVENTION IN NONVALVULAR ATRIAL-FIBRILLATION - A REVIEW OF PROSPECTIVE RANDOMIZED TRIALS [J].
ALBERS, GW ;
SHERMAN, DG ;
GRESS, DR ;
PAULSETH, JE ;
PETERSEN, P .
ANNALS OF NEUROLOGY, 1991, 30 (04) :511-518
[3]  
ALTMAN R, 1991, J THORAC CARDIOV SUR, V101, P427
[4]   HEREDITARY WARFARIN RESISTANCE - INVESTIGATION OF A RARE PHENOMENON [J].
ALVING, BM ;
STRICKLER, MP ;
KNIGHT, RD ;
BARR, CF ;
BERENBERG, JL ;
PECK, CC .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) :499-501
[5]  
Amato MG, 1998, JAMA-J AM MED ASSOC, V280, P695
[6]   Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis [J].
Anand, SS ;
Yusuf, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2058-2067
[7]  
[Anonymous], 1987, HEMATOL REV
[8]  
ATWOOD JE, 1993, HERZ, V18, P27
[9]  
BECHTOLD H, 1984, THROMB HAEMOSTASIS, V51, P358
[10]   Acetaminophen and warfarin - Undesirable synergy [J].
Bell, WR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (09) :702-703